Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells
Targeted delivery of chemotherapeutics and diagnostic agents conjugated to carrier ligands has made significant progress in recent years, both in regards to the structural design of the conjugates and their biological effectiveness. The goal of targeting specific cell surface receptors through struc...
Main Authors: | Yosi Gilad, Michael Firer, Gary Gellerman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-05-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-9059/4/2/11 |
Similar Items
-
Targeted drug delivery for cancer therapy: the other side of antibodies
by: Firer Michael A, et al.
Published: (2012-11-01) -
Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells
by: Kalishwaralal Kalimuthu, et al.
Published: (2018-03-01) -
On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site
by: Eirinaios I. Vrettos, et al.
Published: (2018-04-01) -
Cell-penetrating peptides as part of therapeutics used in cancer research
by: Martin Matijass, et al.
Published: (2021-06-01) -
Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives
by: Diego Tesauro, et al.
Published: (2019-01-01)